In the context of an introduction to your coverage, how do you evaluate names in the medtech space? Mr. Zimmerman: The lens we look through is consistency of execution, whether internal expectations ...

We had the chance to interview you a couple years ago, and when we spoke in October 2023, your company was mainly focused on advancing the drug-eluting version of its CanGaroo bioenvelope. What is the ...

So, we spoke last year, but just as a brief refresher to our readers, can you share an overview or history of the company and how it’s evolved over the years? Mr. Sofer: Yes, of course. We established ...

For readers who are not familiar with Butterfly Network, give us a short introduction. What problem are you solving, and why does ultrasound-on-chip matter clinically and economically? Mr. DeVivo: ...

In the context of an introduction to your coverage, could you define the life sciences space, and discuss how it differs from the biotech or medtech space? Ms. Utterback: The life science companies ...

Tell us briefly about Picard Medical and the history of SynCardia Total Artificial Heart. Mr. Schnegelsberg: Let me start with SynCardia and then go to Picard. SynCardia is a company with a long ...

It’s been a few years since we featured the company. So could you give us a brief history and some milestones for Aclarion? Mr. Ness: Certainly. We successfully completed an IPO in April of 2022. And ...

For readers who are not familiar with SINTX, give us a brief overview of the company and how it evolved into what it is today. Mr. Olson: SINTX was founded on the use of silicon nitride ceramic ...

For readers who may just be hearing about HeartBeam, explain to us what clinical problem you are trying to solve and why hasn’t that been able to be solved with existing cardiac monitoring tools? Mr.

Complete Access to New Interviews, the Archive, and all Special Reports.

Interview with Portfolio Manager for Lord Abbett responsible for directing innovation and growth equity research ...

David Schuster is the Portfolio Manager for Brown Advisory’s Small-Cap Fundamental Value strategy. Prior to joining Brown Advisory in 2008, he was a Managing Director for the financial institutions ...